Canada’s top health officials quietly signed secrecy pacts to shield the Trudeau government’s image during pandemic vaccine deals, triggering outrage over transparency and public trust.
At a Glance
- Senior officials signed NDAs during billion-dollar vaccine negotiations
- Confidentiality move aimed to protect the Trudeau government’s credibility
- Vaccine Injury Support Program received $36M in emergency top-ups
- Parliament was blocked from reviewing federal vaccine contracts
- Deaths linked to “unspecified causes” surged post-vaccine rollout
A Cloak of Silence
Documents obtained through transparency requests have revealed that Dr. Theresa Tam and top federal health officials were asked to sign Non-Disclosure Agreements (NDAs) during the peak of Canada’s pandemic response. This secrecy campaign, coordinated by Public Health Agency leadership and other departments, coincided with massive vaccine purchases from Pfizer, Moderna, and AstraZeneca.
The confidentiality push occurred just as the Trudeau government announced a $1 billion initiative to help provinces roll out vaccine passports. While British Columbia and Quebec embraced the system, Alberta and Ontario resisted, citing fears of social division. Critics now argue that the NDAs weren’t about public safety—but political image control.
Watch a report: Inside Canada’s COVID-19 Transparency Crisis.
Alan Thom, who managed vaccine supply logistics, disclosed that the NDAs were initially justified to avoid embarrassment: “At a certain point…the Department of Public Works determined individual non-disclosure agreements were no longer needed.” But Parliament was already blocked from reviewing key contracts, prompting warnings that democratic oversight was being dangerously curtailed.
Fallout and Growing Distrust
As critics dig deeper, Canada’s Vaccine Injury Support Program (VISP) has emerged as another flashpoint. Originally budgeted at $75 million, the fund required an emergency infusion of $36 million as compensation claims surged. Even with low public demand, Ottawa continued to secure more vaccine doses—including a new inhale-able mRNA candidate still in Phase 2 trials.
Meanwhile, Statistics Canada data show a troubling rise in deaths classified as COVID-related or from “unspecified causes” following the rollout. These figures have fueled media scrutiny and public suspicion, particularly in light of the government’s expanding pharmaceutical ties and information lockdown.
In defense, Prime Minister Justin Trudeau reaffirmed the policies as essential to safety and recovery: “It keeps people safe. It encourages everyone to do the right thing. It keeps our businesses open and our economy rebuilding.”
But with trust in institutions already strained, the marriage of secrecy and pandemic policymaking is deepening the rift between Ottawa and the public it serves.
